Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Diabetes
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Diabetes
    Telmisartan Does Not Significantly Reduce Risk of Recurrent Stroke, Cardiovascular Events - (DGNews)
    Percutaneous Coronary Intervention Not Inferior to Bypass Grafting in Diabetic Patients With Multivessel Disease: Presented at ESC - (DGDispatch)
    Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis - (BMJ)
    TopAbstracts in Diabetes 09/02/2008 - (DGNews)
    Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events - (N Engl J Med)

    News archive

     Recent webcasts/CME - Diabetes
      Cardiometabolic Risk and Risk Management
      An Evolving Approach to the Treatment of Type 2 Diabetes
      Obesity, Type 2 Diabetes, and Cardiovascular Disease
      Global Perspectives on Diabetic Retinopathy: More Than Meets the Eye
      Type 1 Diabetes - New Insights into Pathophysiology, Treatment, and the Search for a Cure

      Webcasts/CME archive

       Recent cases - Diabetes
        Diabetic Fetopathy Associated with Bilateral Adrenal Hyperplasia and Ambiguous Genitalia: A Case Report
        Somatostatinoma: A Rare Cause of Diabetic Ketosis
        New Onset Diabetes Complicated by Haemolysis and Rhabdomyolysis: A Case Report and Review of the Literature
        Diabetic Control and Atypical Antipsychotics: A Case Report
        Treatment with Pioglitazone Induced Significant, Reversible Mitral Regurgitation

        Cases archive
          




        my personal edition > diabetes > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        ERRATUM: Higher Risk Patients Benefit More After Conversion from Pioglitazone to Rosiglitazone: Presented at AACE

        There was an error in the title of our DG Dispatch (May 4, 2006) based on a presentation at the American Association of Clinical Endocrinologists (AACE) annual meeting.

        The title should have stated as follows:

        Higher Risk Patients Benefit More After Conversion from Rosiglitazone to Pioglitazone


        We apologise to the manufacturer for having published inaccurate information on their product.

        We are committed to providing the most accurate, relevant and balanced information for physicians worldwide and have devoted considerable resources to ensuring this. We deeply regret this error.



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send